Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National, Prospective, Multicentre Post Market Surveillance Study on "Patient Reported Outcome" of Implant Based Primary or Secondary Reconstructive Breast Surgery After Mastectomy Using the Complete Resorbable Synthetic TIGR® Matrix

NCT06511167 is registered in ClinicalTrials.gov with AWOgyn as lead sponsor.

NCT NCT06511167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06511167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National, Prospective, Multicentre Post Market Surveillance Study on "Patient Reported Outcome" of Implant Based Primary or Secondary Reconstructive Breast Surgery After Mastectomy Using the Complete Resorbable Synthetic TIGR® Matrix
Lead sponsor
AWOgyn
Phase
Observational
Overall status
Recruiting
Start date
November 8, 2024
Completion date
January 31, 2029
Enrollment
135 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

implant based breast reconstruction